<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Symptom Advice .com &#187; mechanism of action</title>
	<atom:link href="http://symptomadvice.com/tag/mechanism-of-action/feed/" rel="self" type="application/rss+xml" />
	<link>http://symptomadvice.com</link>
	<description></description>
	<lastBuildDate>Tue, 29 May 2012 22:17:13 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.0.1</generator>
		<item>
		<title>Viridian Coleus Forskholii</title>
		<link>http://symptomadvice.com/viridian-coleus-forskholii/</link>
		<comments>http://symptomadvice.com/viridian-coleus-forskholii/#comments</comments>
		<pubDate>Sun, 06 Feb 2011 00:51:15 +0000</pubDate>
		<dc:creator>Symptom Advice</dc:creator>
				<category><![CDATA[mouth symptoms]]></category>
		<category><![CDATA[allergic conditions]]></category>
		<category><![CDATA[arteries]]></category>
		<category><![CDATA[insulin secretion]]></category>
		<category><![CDATA[mast cell degranulation]]></category>
		<category><![CDATA[mechanism of action]]></category>

		<guid isPermaLink="false">http://symptomadvice.com/viridian-coleus-forskholii/</guid>
		<description><![CDATA[Viridian Coleus Forskholii The basic mechanism of action of Coleus is &#116;&#104;&#101; activation of an enzyme, adenylate cyclase, which increases &#116;&#104;&#101; &#097;&#109;&#111;&#117;&#110;&#116; of cyclic adenosine monophosphate (cAMP) &#105;&#110; cells. Cyclic AMP is perhaps &#116;&#104;&#101; &#109;&#111;&#115;&#116; &#105;&#109;&#112;&#111;&#114;&#116;&#097;&#110;&#116; cell regulating compound. &#111;&#110;&#099;&#101; formed &#105;&#116; activates &#109;&#097;&#110;&#121; &#111;&#116;&#104;&#101;&#114; enzymes involved &#105;&#110; diverse cellular functions. &#116;&#104;&#101; effects of raised [...]]]></description>
			<content:encoded><![CDATA[<p></p><p><img src="http://symptomadvice.com/wp-content/uploads/2011/02/1296953475-90.jpg" style="clear:both;clear:both;margin:0 15px 15px 0;width:500px" />
<p><strong>Viridian Coleus Forskholii</strong></p>
<p>The basic mechanism of action of Coleus is &#116;&#104;&#101; activation of an enzyme, adenylate cyclase, which increases &#116;&#104;&#101; &#097;&#109;&#111;&#117;&#110;&#116; of cyclic adenosine monophosphate (cAMP) &#105;&#110; cells. Cyclic AMP is perhaps &#116;&#104;&#101; &#109;&#111;&#115;&#116; &#105;&#109;&#112;&#111;&#114;&#116;&#097;&#110;&#116; cell regulating compound. &#111;&#110;&#099;&#101; formed &#105;&#116; activates &#109;&#097;&#110;&#121; &#111;&#116;&#104;&#101;&#114; enzymes involved &#105;&#110; diverse cellular functions. &#116;&#104;&#101; effects of raised cAMP include: inhibition of mast cell degranulation &#097;&#110;&#100; histamine release, inhibition of platelet activation &#097;&#110;&#100; degranulation, increased force of contraction of heart muscle, relaxation of &#116;&#104;&#101; arteries &#097;&#110;&#100; &#111;&#116;&#104;&#101;&#114; smooth muscles, increased insulin secretion, increased thyroid function, &#097;&#110;&#100; increased lypolysis (fat breakdown).  Note: smooth muscle refers to &#116;&#104;&#101; tissue &#102;&#111;&#117;&#110;&#100; &#105;&#110; &#116;&#104;&#101; bronchials, GI tract, uterus, bladder &#097;&#110;&#100; arteries.</p>
<p><strong>• ANTI-ALLERGIC</strong> – Conditions such as eczema &#097;&#110;&#100; asthma &#097;&#114;&#101; characterised &#098;&#121; &#097; relative decrease &#105;&#110; cAMP &#105;&#110; &#116;&#104;&#101; skin &#097;&#110;&#100; bronchial smooth muscle, respectively. &#116;&#104;&#101; effect of &#116;&#104;&#105;&#115; causes mast cell degranulation &#097;&#110;&#100; smooth muscle contraction &#097;&#108;&#111;&#110;&#103; &#119;&#105;&#116;&#104; excessive levels of platelet activating factor (PAF). PAF plays &#097; central role &#105;&#110; &#109;&#097;&#110;&#121; inflammatory &#097;&#110;&#100; allergic responses including bronchoconstriction &#097;&#110;&#100; reduced coronary blood flow. &#109;&#111;&#115;&#116; modern drugs &#102;&#111;&#114; allergic symptoms &#097;&#114;&#101; designed to increase cAMP levels. Coleus achieves &#116;&#104;&#105;&#115; through improving enzyme activity &#119;&#105;&#116;&#104;&#111;&#117;&#116; negative &#115;&#105;&#100;&#101; effects.</p>
<p><strong>• SKIN CELL REGULATOR</strong> – Psoriasis is &#097; common skin disorder believed to &#098;&#101; caused &#098;&#121; &#097; decrease &#105;&#110; cAMP &#105;&#110; relation to &#097;&#110;&#111;&#116;&#104;&#101;&#114; cell-regulating substance, cyclic guanine monophosphate (cGMP). &#116;&#104;&#101; result of &#116;&#104;&#105;&#115; is &#097; dramatic increase &#105;&#110; cell division (1000 times &#116;&#104;&#101; normal level). Studies &#104;&#097;&#118;&#101; indicated that Coleus may &#098;&#101; &#118;&#101;&#114;&#121; &#117;&#115;&#101;&#102;&#117;&#108; &#102;&#111;&#114; psoriasis sufferers &#098;&#101;&#099;&#097;&#117;&#115;&#101; of &#105;&#116;&#115; balancing effect &#111;&#110; cAMP &#097;&#110;&#100; cGMP.</p>
<p><strong>• CARDIOVASCULAR SUPPORT</strong> – &#111;&#110;&#101; of &#116;&#104;&#101; &#109;&#111;&#115;&#116; beneficial aspects of Coleus appears to &#098;&#101; relating to &#105;&#116;&#115; &#117;&#115;&#101; &#105;&#110; conditions such as hypertension, congestive heart failure, &#097;&#110;&#100; angina. Coleus &#104;&#097;&#115; been shown to reduce blood pressure &#097;&#108;&#111;&#110;&#103; &#119;&#105;&#116;&#104; improving &#116;&#104;&#101; contractility of &#116;&#104;&#101; heart. &#116;&#104;&#105;&#115; improvement &#105;&#110; function appears to &#098;&#101; &#109;&#097;&#105;&#110;&#108;&#121; &#100;&#117;&#101; to &#116;&#104;&#101; increase &#105;&#110; cAMP. Coleus is also noted &#102;&#111;&#114; &#105;&#116;&#115; effects &#111;&#110; reducing platelet aggregation &#097;&#110;&#100; acting as &#097; direct cerebral vasodilator.</p>
<p><strong>• WEIGHT CONTROL / HYPOTHYROIDISM</strong> – Coleus may offer benefit through regulating lypolysis (breakdown of stored fat) &#097;&#110;&#100; increasing thyroid hormone production &#097;&#110;&#100; release.</p>
<p><strong>• MALABSORPTION AND DIGESTIVE DISORDERS</strong> – Coleus stimulates digestive secretions i.e. HCL, pepsin, amylase &#097;&#110;&#100; pancreatic enzymes. Coleus &#104;&#097;&#115; also demonstrated effects &#105;&#110; improving nutrient absorption &#105;&#110; &#116;&#104;&#101; small intestine as &#119;&#101;&#108;&#108; as improving &#116;&#104;&#101; release of salivary amylase (helpful &#105;&#110; cases of dry mouth).</p>
<p><strong>Dosage</strong></p>
<p>50mg two to &#116;&#104;&#114;&#101;&#101; times daily, standardised to &#099;&#111;&#110;&#116;&#097;&#105;&#110; 10 percent forskolin.</p>
<p><strong>Potential applications</strong></p>
<p>Eczema / Psoriasis, cardiovascular disease, respiratory disorders, allergic conditions, glaucoma, weight control, IBS, dry mouth syndrome, immune enhancement.</p>
<p><strong>Known contraindications</strong></p>
<p>Caution suggested &#105;&#110; &#116;&#104;&#111;&#115;&#101; &#119;&#105;&#116;&#104; peptic ulcer &#111;&#114; hypotension.</p>
<p><strong>Interactions</strong></p>
<p>Caution &#105;&#110; &#116;&#104;&#111;&#115;&#101; taking anti-coagulant, antihypertensive, &#097;&#110;&#100; antiasthmatic medication as &#105;&#116; may potentiate &#116;&#104;&#101; effects of these drugs.</p>
<p><strong>Useful links</strong></p>
<p>May &#098;&#101; particularly &#117;&#115;&#101;&#102;&#117;&#108; &#105;&#110; combination &#119;&#105;&#116;&#104; Hawthorn &#105;&#110; &#115;&#111;&#109;&#101; cases. &#111;&#116;&#104;&#101;&#114; links include milk thistle, digestive enzymes, quercetin, flax/hemp seed oil.</p>
<p>More &#102;&#114;&#111;&#109; Viridian Nutrition, Certified Organic Vitamins &amp; Supplements</p></p>
]]></content:encoded>
			<wfw:commentRss>http://symptomadvice.com/viridian-coleus-forskholii/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Buy Diapam online, order Diapam</title>
		<link>http://symptomadvice.com/buy-diapam-online-order-diapam/</link>
		<comments>http://symptomadvice.com/buy-diapam-online-order-diapam/#comments</comments>
		<pubDate>Thu, 25 Nov 2010 21:51:14 +0000</pubDate>
		<dc:creator>Symptom Advice</dc:creator>
				<category><![CDATA[mouth symptoms]]></category>
		<category><![CDATA[action of diazepam]]></category>
		<category><![CDATA[mechanism of action]]></category>
		<category><![CDATA[sedative]]></category>
		<category><![CDATA[spinal reflexes]]></category>

		<guid isPermaLink="false">http://symptomadvice.com/buy-diapam-online-order-diapam/</guid>
		<description><![CDATA[November 25, 2010 – 7:00 pm Prescription &#110;&#097;&#109;&#101;: Diapam International &#110;&#097;&#109;&#101;: Diazepam (Diazepam) Group affiliation: anxiolytic tool Description active substance (INN): Diazepam Dosage form: tablet, solution for intravenous and intramuscular injection, injection, tablets, coated tablets, coated tablets [for children] Pharmacological action: anxiolytic drug (anxiolytic) benzodiazepine. &#104;&#097;&#115; a sedative-hypnotic, anticonvulsant and central miorelaksiruyuschee action. &#116;&#104;&#101; mechanism [...]]]></description>
			<content:encoded><![CDATA[<p></p><p><img src="http://symptomadvice.com/wp-content/uploads/2010/11/1290721874-22.jpg" style="clear:both;clear:both;margin:0 15px 15px 0;width:500px" />November 25, 2010 – 7:00 pm
<p> Prescription &#110;&#097;&#109;&#101;: Diapam </p>
<p> International &#110;&#097;&#109;&#101;: Diazepam (Diazepam) </p>
<p> Group affiliation: anxiolytic tool </p>
<p> Description active substance (INN): Diazepam </p>
<p> Dosage form: tablet, solution for intravenous and intramuscular injection, injection, tablets, coated tablets, coated tablets [for children] </p>
<p> Pharmacological action: anxiolytic drug (anxiolytic) benzodiazepine. &#104;&#097;&#115; a sedative-hypnotic, anticonvulsant and central miorelaksiruyuschee action. &#116;&#104;&#101; mechanism of action of diazepam &#105;&#115; due &#116;&#111; stimulation of benzodiazepine receptor supramolecular GABA-benzodiazepine-hlorionofor receptor complex, leading &#116;&#111; increased inhibitory action of GABA (neurotransmitter pre-and postsynaptic inhibition in &#097;&#108;&#108; &#112;&#097;&#114;&#116;&#115; of &#116;&#104;&#101; CNS) &#116;&#111; &#116;&#104;&#101; transmission of nerve impulses. Stimulates benzodiazepine receptors located in &#116;&#104;&#101; allosteric center of postsynaptic GABA receptors of &#116;&#104;&#101; ascending activating brain stem reticular formation and lateral horn neurons of &#116;&#104;&#101; spinal cord, reduces &#116;&#104;&#101; excitability of &#116;&#104;&#101; subcortical brain structures (limbic &#115;&#121;&#115;&#116;&#101;&#109;, thalamus, hypothalamus), inhibits &#116;&#104;&#101; polysynaptic spinal reflexes. Anxiolytic effects due &#116;&#111; &#116;&#104;&#101; influence on &#116;&#104;&#101; amygdaloid complex of &#116;&#104;&#101; limbic &#115;&#121;&#115;&#116;&#101;&#109; and appears &#116;&#111; reduce &#116;&#104;&#101; emotional stress, reducing anxiety, fear, anxiety. Sedation due &#116;&#111; &#116;&#104;&#101; influence on &#116;&#104;&#101; reticular formation of &#116;&#104;&#101; brain stem and nonspecific thalamic nucleus and manifests a decrease in symptoms of neurotic origin (anxiety, fear). &#116;&#104;&#101; main mechanism of action of sleeping pills &#105;&#115; &#116;&#104;&#101; oppression of &#116;&#104;&#101; cells of &#116;&#104;&#101; reticular formation of &#116;&#104;&#101; brain. Anticonvulsant action &#105;&#115; realized by increasing presynaptic inhibition. Reduces spread of epileptogenic activity, &#098;&#117;&#116; &#110;&#111;&#116; removed &#116;&#104;&#101; excited state of &#116;&#104;&#101; hearth. Central miorelaksiruyuschee action &#105;&#115; caused by inhibition of spinal polysynaptic afferent inhibitory ways (to a lesser extent and monosynaptic). &#105;&#116; &#105;&#115; possible, and direct inhibition of motor nerve and muscle function. With moderate sympatholytic activity, may decrease blood pressure and increased coronary blood vessels. Increases &#116;&#104;&#101; threshold of pain sensitivity. Suppresses sympathadrenalic and parasympathetic (including vestibular) paroxysms. Reduces nocturnal secretion of gastric juice. &#116;&#104;&#101; action of &#116;&#104;&#101; drug &#105;&#115; observed in 2-7 day of treatment. On &#116;&#104;&#101; productive psychotic symptoms genesis (acute delusional, hallucinatory, affective disorders) &#104;&#097;&#115; practically no effect, &#105;&#115; rarely observed decrease in affective intensity, delusional disorders. When abstinent syndrome in chronic alcoholism &#099;&#097;&#117;&#115;&#101;&#115; a weakening of agitation, tremor, negativism, &#097;&#115; &#119;&#101;&#108;&#108; &#097;&#115; alcoholic delirium and hallucinations. &#116;&#104;&#101; therapeutic effect in patients with &#102;&#097;&#108;&#115;&#101; angina, arrhythmias, and paresthesia observed by &#116;&#104;&#101; end of 1 week. </p>
<p> Indications: Anxiety disorders. Dysphoria (consisting of combination therapy &#097;&#115; &#097;&#110; additional LAN). Insomnia (difficulty falling asleep). Spasm of skeletal muscle &#117;&#110;&#100;&#101;&#114; local injury, spastic conditions associated with &#100;&#097;&#109;&#097;&#103;&#101; &#116;&#111; &#116;&#104;&#101; brain or spinal cord (cerebral palsy, athetosis, tetanus), myositis, bursitis, arthritis, rheumatoid pelvispondiloartrit, progressive chronic polyarthritis, arthrosis, accompanied by a voltage of skeletal muscles, vertebral syndrome, angina , tension headache. Abstinent alcohol syndrome: anxiety, tension, agitation, tremor, transient reactive states. In &#116;&#104;&#101; combined therapy: hypertension, peptic ulcer and 12 duodenal ulcer; psychosomatic disorders in obstetrics and gynecology: menopausal and menstrual disorders, preeclampsia, status epilepticus, eczema and &#111;&#116;&#104;&#101;&#114; diseases accompanied by itching, irritability. Meniere&#8217;s disease. Poisoning drugs. Premedication before surgical interventions, and endoscopic manipulation, general anesthesia. For parenteral administration: premedication before general anesthesia, &#097;&#115; a component of combined general anesthesia, myocardial infarction (in &#116;&#104;&#101; complex therapy); motor stimulation of &#100;&#105;&#102;&#102;&#101;&#114;&#101;&#110;&#116; etiologies in neurology and psychiatry paranoid-hallucinatory state, epileptic seizures (docking); relief in labor, premature genera (only at &#116;&#104;&#101; end of III trimester of pregnancy); premature exfoliation of &#116;&#104;&#101; placenta. </p>
<p> Contraindications: Hypersensitivity, coma, shock, acute alcohol intoxication with &#116;&#104;&#101; weakening of vital functions, acute intoxication of drugs , &#104;&#097;&#118;&#101; a depressing effect on &#116;&#104;&#101; central nervous &#115;&#121;&#115;&#116;&#101;&#109; (including narcotic analgesics and hypnotics drugs), myasthenia gravis, angle-closure glaucoma (acute onset or predisposition), severe COPD (risk of progression of &#116;&#104;&#101; degree of respiratory failure), acute respiratory failure, absans syndrome or Lennox-Gastaut (with a / in &#116;&#104;&#101; introduction contributes &#116;&#111; &#116;&#104;&#101; tonic status epilepticus), pregnancy (especially &#116;&#104;&#101; I trimester), lactation, children younger &#116;&#104;&#097;&#110; 6 months (ingestion), and 30 days inclusive (with &#116;&#104;&#101; / m and / in &#116;&#104;&#101; introduction). C carefully. Epilepsy or seizures in history (start of treatment with diazepam or abrupt withdrawal may accelerate &#116;&#104;&#101; development of seizures or status epilepticus), liver and / or renal failure, cerebral and spinal ataxia, hyperkinesis, drug dependency history, &#116;&#104;&#101; propensity &#116;&#111; abuse drugs, organic diseases brain, hypoproteinemia, sleep apnea (or suspected), advanced age. </p>
<p> Side effects: of &#116;&#104;&#101; nervous &#115;&#121;&#115;&#116;&#101;&#109;: at &#116;&#104;&#101; beginning of treatment (particularly in elderly patients) &#8211; drowsiness dizziness, fatigue, reduced ability &#116;&#111; concentrate, ataxia, disorientation, unsteady gait and poor coordination of movements, apathy, blunting of emotions, mental retardation and motor reactions, anterograde amnesia (in more often &#116;&#104;&#097;&#110; when taking &#111;&#116;&#104;&#101;&#114; benzodiazepines), rarely &#8211; headache, euphoria, depression, tremor, depressed mood, catalepsy, confusion, dysautonomic extrapyramidal reactions (uncontrolled movements of body, including eyes), weakness, myasthenia gravis during &#116;&#104;&#101; day, hyporeflexia, dysarthria, very rarely &#8211; paradoxical reactions (aggressive outbursts, psychomotor anxiety, fear, suicidal tendencies, muscle spasms, confusion, hallucinations, severe agitation, irritability, anxiety, insomnia). From &#116;&#104;&#101; side of hematopoiesis: leukopenia, neutropenia, agranulocytosis (chills, pyrexia, sore throat, extreme tiredness or weakness), anemia, and thrombocytopenia. On &#116;&#104;&#101; &#112;&#097;&#114;&#116; of &#116;&#104;&#101; digestive &#115;&#121;&#115;&#116;&#101;&#109;: dry mouth or hyperptyalism, heartburn, hiccups, stomachalgia, nausea, vomiting, decreased appetite, constipation, liver problems, increased activity of &#8220;liver&#8221; transaminases and alkaline phosphatase, jaundice. From &#116;&#104;&#101; CCC: palpitations, tachycardia, blood pressure reduction (with parenteral administration). On &#116;&#104;&#101; &#112;&#097;&#114;&#116; of &#116;&#104;&#101; genitourinary &#115;&#121;&#115;&#116;&#101;&#109;: urinary incontinence, urinary retention, renal failure, increased or decreased libido, dysmenorrhea. Allergic reactions: skin rash, itching. Effect on &#116;&#104;&#101; fetus: teratogenicity (especially &#116;&#104;&#101; I trimester), CNS depression, respiratory failure and &#116;&#104;&#101; suppression of sucking reflex in infants &#119;&#104;&#111;&#115;&#101; mothers &#117;&#115;&#101;&#100; &#116;&#104;&#101; drug. Local reactions: at &#116;&#104;&#101; injection site &#8211; phlebitis or venous thrombosis (redness, swelling or pain at &#116;&#104;&#101; injection site). &#111;&#116;&#104;&#101;&#114;: addiction, drug dependency, rarely &#8211; inhibition of &#116;&#104;&#101; respiratory center, respiratory dysfunction, impaired vision (diplopia), bulimia, body weight loss. With a sharp decrease in dose or cessation of reception &#8211; syndrome &#8220;cancel&#8221; (irritability, headache, anxiety, agitation, excitement, fear, nervousness, sleep disturbances, dysphoria, a spasm of smooth muscles of internal organs and skeletal muscles, depersonalization, increased sweating, depression, nausea, vomiting, tremors, disorders of perception, including giperakuziya, paresthesia, photophobia, tachycardia, convulsions, hallucinations, rare &#8211; acute psychosis). When &#117;&#115;&#101;&#100; in obstetrics &#8211; in term and preterm children &#8211; muscular hypotension, hypothermia, dyspnoea. Overdose. Symptoms: drowsiness, confusion, paradoxical excitement, reduced reflexes, arefleksiya, stupor, decreased response &#116;&#111; pain stimuli, deep sleep, dysarthria, ataxia, visual disturbances (nystagmus), tremor, bradycardia, dyspnea or labored breathing, apnea, &#109;&#097;&#114;&#107;&#101;&#100; weakness, lowering blood pressure, collapse, depression of cardiac and respiratory activity, coma. Treatment: gastric lavage, forced diuresis, receiving activated charcoal. Symptomatic therapy (maintenance of respiration and blood pressure), mechanical ventilation. &#097;&#115; a specific antagonist flumazenil &#117;&#115;&#101; (in a hospital). Hemodialysis &#105;&#115; ineffective. &#116;&#104;&#101; antagonist of benzodiazepines flyumazenil &#110;&#111;&#116; shown in patients with epilepsy who &#119;&#101;&#114;&#101; treated with benzodiazepines. In such patients antagonistic action with respect &#116;&#111; benzodiazepines &#099;&#097;&#110; provoke &#116;&#104;&#101; development of epileptic seizures. </p>
<p> Dosage and administration: inside, in / m / v, rectally. &#116;&#104;&#101; dose &#105;&#115; calculated individually depending on &#116;&#104;&#101; patient, &#116;&#104;&#101; clinical picture of disease, sensitivity &#116;&#111; &#116;&#104;&#101; drug. &#097;&#115; &#097;&#110; anxiolytic drugs appointed interior, 2. 5-10 mg 2-4 times a day. Psychiatry: in neurosis, hysterical or hypochondriacal reactions, states of dysphoria &#100;&#105;&#102;&#102;&#101;&#114;&#101;&#110;&#116; genesis, phobias &#8211; of 5-10 mg 2-3 times a day. &#105;&#102; necessary, &#116;&#104;&#101; dose may &#098;&#101; increased &#116;&#111; 60 mg / day. When alcohol withdrawal syndrome &#8211; 10 mg 3-4 times a day during &#116;&#104;&#101; &#102;&#105;&#114;&#115;&#116; 24 h, with a subsequent decrease &#116;&#111; 5 mg 3-4 times a day. Elderly, debilitated patients and patients with atherosclerosis in &#116;&#104;&#101; beginning of treatment &#8211; by mouth, 2 mg 2 times a day, &#105;&#102; necessary, &#098;&#101; increased &#116;&#111; optimum effect. A working patient &#105;&#115; recommended &#116;&#111; take 2. 5 mg 1-2 times daily or 5 mg (base dose) in &#116;&#104;&#101; evening. Neurology: spastic states of central origin in degenerative neurological diseases &#8211; mouth, 5-10 mg 2-3 times a day. Cardiology and Rheumatology: Angina &#8211; at 2-5 mg 2-3 times a day, hypertension &#8211; at 2-5 mg 2-3 times a day, vertebral syndrome with bedrest &#8211; 10 mg 4 times a day, and &#097;&#115; additional drugs in Physical Therapy in Rheumatoid pelvispondiloartrite, progressive chronic polyarthritis, arthrosis &#8211; 5 mg 1-4 times a day. In &#116;&#104;&#101; combined therapy of myocardial infarction: initial dose &#8211; 10 mg / m, then &#116;&#104;&#101; inside of 5-10 mg 1-3 times a day, and premedication in &#116;&#104;&#101; case of defibrillation &#8211; 10-30 mg / in slowly (single dose), spastic state rheumatic origin, vertebral syndrome &#8211; &#097;&#110; initial dose of 10 mg / m, then inside, 5 mg 1-4 times a day. Obstetrics and Gynecology: psychosomatic disorders, menopausal and menstrual disorders, preeclampsia &#8211; at 2-5 mg 2-3 times a day. Pre-eclampsia &#8211; initial dose &#8211; 10-20 mg / in, &#102;&#111;&#108;&#108;&#111;&#119;&#101;&#100; by 5-10 mg by mouth 3 times daily; eclampsia &#8211; during a crisis &#8211; in / at 10-20 mg, &#102;&#111;&#108;&#108;&#111;&#119;&#101;&#100; &#105;&#102; necessary in / jet or drip, does &#110;&#111;&#116; more &#116;&#104;&#097;&#110; 100 mg / day. &#116;&#111; facilitate labor when cervix dilated 2-3 toe &#8211; i / m 20 mg, with premature delivery and premature placental abruption &#8211; a / m in &#116;&#104;&#101; initial dose of 20 mg over 1 hour introduction of &#116;&#104;&#101; same dose &#105;&#115; repeated; maintenance doses &#8211; of 10 mg 4 times up &#116;&#111; 20 mg 3 times a day. In preterm placental abruption treatment &#105;&#115; carried &#111;&#117;&#116; without interruption &#8211; &#116;&#111; &#116;&#104;&#101; ripening fruit. Anesthesiology, Surgery: premedication &#8211; on &#116;&#104;&#101; eve of &#116;&#104;&#101; operation, in &#116;&#104;&#101; evening &#8211; 10-20 mg orally, preparation for surgery &#8211; for 1 h prior &#116;&#111; anesthesia / m adults &#8211; 10-20 mg, children &#8211; 2. 5-10 mg; introduction &#116;&#111; anesthesia &#8211; in / in 0. 2-0. 5 mg / kg for short-term narcotic sleep with sophisticated diagnostic and therapeutic interventions in therapy and surgery &#8211; in / in adults &#8211; 10-30 mg, for children &#8211; 0. 1-0. 2 mg / kg. Pediatrics: psychosomatic and reactive disorders, spastic states of central origin &#8211; appoint a gradual increase in dose (starting with low doses and slowly increasing them &#117;&#110;&#116;&#105;&#108; &#116;&#104;&#101; optimal dose &#105;&#115; &#119;&#101;&#108;&#108; tolerated sick), daily intake (can &#098;&#101; divided &#105;&#110;&#116;&#111; 2-3 reception, with &#116;&#104;&#101; bulk, &#116;&#104;&#101; &#108;&#097;&#114;&#103;&#101;&#115;&#116; dose, &#116;&#097;&#107;&#101;&#110; at night): Inside, up &#116;&#111; 6 months &#105;&#115; &#110;&#111;&#116; recommended, 6 months and older &#8211; 1-2. 5 mg, or 40-200 mg / kg, or 1. 6.17 mg / sq. m, 3-4 times a day. Inside, from 1 &#116;&#111; 3 years &#8211; 1 mg, from 3 &#116;&#111; 7 years &#8211; 2 mg, from 7 years and older &#8211; 5.3 mg. Daily dose &#8211; 2, 6 and 8-10 mg, &#114;&#101;&#115;&#112;&#101;&#099;&#116;&#105;&#118;&#101;&#108;&#121;. Parenteral, status epilepticus and severe recurrent epileptic seizures: children from 30 days &#116;&#111; 5 years &#8211; in / in (slowly) 0. 2-0. 5 mg every 2-5 minutes up &#116;&#111; a maximum dose of 5 mg of 5 years and over &#8211; 1 mg every 2-5 minutes up &#116;&#111; a maximum dose of 10 mg, &#105;&#102; necessary, treatment &#099;&#097;&#110; &#098;&#101; repeated &#097;&#102;&#116;&#101;&#114; 2-4 h. Muscle relaxation, tetanus: &#116;&#104;&#101; children of 30 days &#116;&#111; 5 years &#8211; i / m or i / v 1-2 mg of 5 years and over &#8211; 5-10 mg, &#105;&#102; necessary, &#116;&#104;&#101; dose may &#098;&#101; repeated every 3-4 h. Patients in elderly care should &#098;&#101;&#103;&#105;&#110; with &#104;&#097;&#108;&#102; &#116;&#104;&#101; usual dose for adults, gradually increasing &#105;&#116;, depending on &#116;&#104;&#101; achieved effect and tolerability. Parenteral with anxiety &#105;&#115; introduced &#105;&#110;&#116;&#111; / in &#116;&#104;&#101; initial dose of 0. 1-0. 2 mg / kg, repeated injections every 8 h &#117;&#110;&#116;&#105;&#108; symptoms disappear, then move on &#116;&#111; oral. When &#116;&#104;&#101; motor excitation &#105;&#115; introduced &#105;&#110;&#116;&#111; &#116;&#104;&#101; / m or / 10-20 mg 3 times a day. In traumatic spinal cord lesions, accompanied by paraplegia or hemiplegia, chorea &#8211; a / m in adults &#097;&#110; initial dose of 10-20 mg, for children &#8211; 2-10 mg. When status epilepticus &#8211; in / at &#116;&#104;&#101; initial dose of 10-20 mg, subsequently, &#105;&#102; necessary &#8211; 20 mg / m or i / v drip. &#105;&#102; you need / &#116;&#111; drip (no more &#116;&#104;&#097;&#110; 4 ml) diluted in 5-10% dextrose or 0. 9% solution of NaCl. &#116;&#111; avoid loss of product in &#116;&#104;&#101; sediment should &#098;&#101; &#117;&#115;&#101;&#100; &#110;&#111;&#116; less &#116;&#104;&#097;&#110; 250 ml infusion solution, quickly and &#116;&#104;&#111;&#114;&#111;&#117;&#103;&#104;&#108;&#121; mix &#116;&#104;&#101; resulting solution. For relief of muscle spasm expressed &#8211; in / at once, or twice 10 mg. Tetanus: &#097;&#110; initial dose &#8211; 0. 1-0. 3 mg / kg at intervals of 1-4 hours or &#097;&#115; a / v infusion 4-10 mg / kg / day. Rectal, &#097;&#115; antiepileptic drugs (status epilepticus and severe recurrent seizures) &#8211; 0. 15-0. 5 mg / kg &#116;&#111; maximum dose &#8211; 20 mg. Children &#8211; 0. 2-0. 5 mg / kg, elderly patients &#8211; 0. 2-0. 3 mg / kg. </p>
<p> Special instructions: In / diazepam in solution must &#098;&#101; injected slowly, &#105;&#110;&#116;&#111; a large vein at &#108;&#101;&#097;&#115;&#116; 1 min for every 5 mg (1 ml) of &#116;&#104;&#101; drug. &#110;&#111;&#116; recommended for continuous i / v infusion &#8211; perhaps precipitation and adsorption of &#116;&#104;&#101; drug polyvinylchloride materials infusion bottles and tubes. In &#116;&#104;&#101; treatment of patients &#105;&#115; strictly prohibited &#116;&#104;&#101; &#117;&#115;&#101; of ethanol. In renal / hepatic failure and prolonged treatment &#105;&#115; necessary &#116;&#111; monitor patterns of peripheral blood and &#8220;liver&#8221; enzymes. &#116;&#104;&#101; risk of drug dependence increases when using large doses, a considerable length of treatment, patients who previously abused drugs or ethanol. Without specific instructions, should &#110;&#111;&#116; &#098;&#101; &#117;&#115;&#101;&#100; for a long time. &#105;&#116; &#105;&#115; unacceptable abrupt discontinuation of treatment &#098;&#101;&#099;&#097;&#117;&#115;&#101; of &#116;&#104;&#101; risk of &#116;&#104;&#101; syndrome of &#8220;lifting&#8221; (headache, myalgia, anxiety, tension, confusion, irritability, and in severe cases &#8211; derealization, depersonalization, giperakuziya, photophobia, tactile hypersensitivity, paresthesias in &#116;&#104;&#101; extremities, hallucinations and epileptic seizures), &#098;&#117;&#116; due &#116;&#111; a slow T1 / 2 of diazepam expressed its manifestation &#105;&#115; &#109;&#117;&#099;&#104; weaker &#116;&#104;&#097;&#110; &#116;&#104;&#097;&#116; of &#111;&#116;&#104;&#101;&#114; benzodiazepines. &#105;&#102; you &#104;&#097;&#118;&#101; any patients with such unusual reactions, &#097;&#115; increased aggressiveness, acute state of excitement, anxiety, fear, suicidal &#116;&#104;&#111;&#117;&#103;&#104;&#116;&#115;, hallucinations, increased muscle cramps, difficult &#116;&#111; fall asleep, shallow sleep, treatment should &#098;&#101; discontinued. &#115;&#116;&#097;&#114;&#116; of treatment with diazepam or its abrupt withdrawal in patients with epilepsy or seizures in history &#099;&#097;&#110; accelerate &#116;&#104;&#101; development of seizures or status epilepticus. During pregnancy, only in exceptional cases and only for &#8220;real life&#8221; testimony. Toxic effect on &#116;&#104;&#101; fetus and increase &#116;&#104;&#101; risk of birth defects when &#117;&#115;&#101;&#100; in &#116;&#104;&#101; I trimester of pregnancy. Therapeutic dose in &#116;&#104;&#101; &#108;&#097;&#116;&#101;&#114; stages of pregnancy &#099;&#097;&#110; cause depression of &#116;&#104;&#101; central nervous &#115;&#121;&#115;&#116;&#101;&#109; of &#116;&#104;&#101; newborn. &#116;&#104;&#101; constant &#117;&#115;&#101; during pregnancy &#099;&#097;&#110; lead &#116;&#111; physical dependence &#8211; &#099;&#097;&#110; syndrome &#8220;cancellation&#8221; of &#116;&#104;&#101; newborn. Children, &#101;&#115;&#112;&#101;&#099;&#105;&#097;&#108;&#108;&#121; at a younger age, &#097;&#114;&#101; very sensitive &#116;&#111; central depressant drug action of benzodiazepines. Babies &#097;&#114;&#101; &#110;&#111;&#116; encouraged &#116;&#111; nominate drugs containing benzyl alcohol &#8211; may develop a fatal toxic syndrome, manifested metabolic acidosis, CNS depression, difficulty breathing, kidney failure, &#108;&#111;&#119;&#101;&#114; blood pressure, and possibly seizures and intracranial hemorrhages. Using (especially in &#116;&#104;&#101; / m or i / v) at doses &#097;&#098;&#111;&#118;&#101; 30 mg for 15 hours before birth or during labor may cause newborn respiratory depression (up &#116;&#111; apnea), decreased muscle tone, &#108;&#111;&#119;&#101;&#114; blood pressure, hypothermia, poor suckling act ( syndrome flaccid child &#8220;) and violation of metabolism in response &#116;&#111; cold stress. During &#116;&#104;&#101; period of treatment must &#098;&#101; careful when driving and &#111;&#116;&#104;&#101;&#114; lesson potentially &#100;&#097;&#110;&#103;&#101;&#114;&#111;&#117;&#115; activities &#119;&#104;&#105;&#099;&#104; require high concentration and speed of psychomotor reactions. </p>
<p> Interaction: strengthens &#116;&#104;&#101; inhibitory effect on CNS ethanol, sedative and antipsychotic drugs (neuroleptics), antidepressants, narcotic analgesics, drugs for general anesthesia, muscle relaxants. Inhibitors of microsomal oxidation (including cimetidine, oral contraceptives, erythromycin, disulfiram, fluoxetine, isoniazid, ketoconazole, metoprolol, propranolol, propoxyphene, valproic acid) extend T1 / 2 and increase &#116;&#104;&#101; effect. Inductors microsomal liver enzymes decrease &#116;&#104;&#101; efficiency. Narcotic analgesics increase &#116;&#104;&#101; euphoria, leading &#116;&#111; &#116;&#104;&#101; rise of psychological dependence. Antacids drugs reduce &#116;&#104;&#101; rate of absorption of diazepam from &#116;&#104;&#101; gastrointestinal tract, &#098;&#117;&#116; &#110;&#111;&#116; its fullness. Antihypertensive drugs may increase &#116;&#104;&#101; severity of BP reduction. Against &#116;&#104;&#101; background of &#116;&#104;&#101; simultaneous appointment of clozapine may &#098;&#101; increased respiratory depression. At simultaneous application with nizkopolyarnymi cardiac glycosides may increase &#116;&#104;&#101; concentration of recent serum and &#116;&#104;&#101; development of digitalis intoxication (as a result of competition for association with plasma proteins). Reduces &#116;&#104;&#101; effectiveness of levodopa in patients with Parkinson&#8217;s disease. Omeprazole prolongs &#116;&#104;&#101; elimination of diazepam. MAO inhibitors, analeptics, psychostimulants &#8211; reduce activity. Premedication with diazepam reduces &#116;&#104;&#101; dose of fentanyl required for &#116;&#104;&#101; induction of general anesthesia, and reduce &#116;&#104;&#101; time needed &#116;&#111; &#8220;switch off&#8221; of consciousness with induction doses. May increase &#116;&#104;&#101; toxicity of zidovudine. Treating may increase &#116;&#104;&#101; excretion of diazepam and decrease its concentration in plasma. Theophylline (used in low doses) may reduce or even distort &#116;&#104;&#101; sedative effect. Pharmaceutical incompatible in &#116;&#104;&#101; same syringe with &#111;&#116;&#104;&#101;&#114; drugs. </p></p>
]]></content:encoded>
			<wfw:commentRss>http://symptomadvice.com/buy-diapam-online-order-diapam/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
